Human Plasma Phospholipid Transfer Protein (PLTP) - Structural and Functional Features

High-Density Lipoproteins: From Basic Biology to Clinical Aspects

Volumn , Issue , 2008, Pages 183-205

  Siggins, Sarah ^a   Rye, Kerry Ann ^a   Olkkonen, Vesa M ^a   Jauhiainen, Matti ^b   Ehnholm, Christian ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Functional features; HDL plasma metabolic factors; High density lipoproteins; Human plasma phospholipid transfer protein (PLTP); Lipid transfer proteins; Structural features

Indexed keywords

EID: 84889332858     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527625178.ch8     Document Type: Chapter

References (146)

1. Linsel-Nitschke, P. and Tall, A. R. (2005) HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nature Rev, 4, 193-205.
2. Fielding, C. J. and Fielding, P. E. (1995) Molecular physiology of reverse cholesterol transport. J. Lipid Res, 36, 211-228.
3. Tall, A. R., Abreu, E., Shuman, J. (1983) Separation of a plasma phospholipid transfer protein from cholesterol ester/phospholipid exchange protein. J Biol Chem, 258 (4), 2174-80.
4. Huuskonen, J., Ekstrom, M., Tahvanainen, E., Vainio, A., Metso, J., Pussinen, P., Ehnholm, C., Olkkonen, V. M., Jauhiainen, M. (2000b) Quantification of human plasma phospholipid transfer protein (PLTP): relationship between PLTP mass and phospholipid transfer activity. Atherosclerosis, 151 (2), 451-61.
5. Huuskonen, J., Olkkonen, V. M., Ehnholm, C., Metso, J., Julkunen, I., Jauhiainen, M. (2000c) Phospholipid transfer is a prerequisite for PLTPmediated HDL conversion. Biochemistry, 39 (51), 16092-16098.
6. Tollefson, J. H., Ravnik, S., Albers, J. J. (1988) Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. J Lipid Res, 29 (12), 1593-602.
7. Day, J. R., Albers, J. J., Lofton-Day, C. E., Gilbert, T. L., Ching, A. F., Grant, F. J., O'Hara, P. J., Marcovina, S. M., Adolphson, J. L. (1994) Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. J Biol Chem, 269 (12), 9388-91.
8. Gray, P. W., Flaggs, G., Leong, S. R., Gumina, R. J., Weiss, J., Ooi, C. E., Elsbach, P. (1989) Cloning of the cDNA of a human neutrophil bactericidal protein. Structural and functional correlations. J Biol Chem, 264 (16), 9505-9.
9. Schumann, R. R., Leong, S. R., Flaggs, G. W., Gray, P. W., Wright, S. D., Mathison, J. C., Tobias, P. S., Ulevitch, R. J. (1990) Structure and function of lipopolysaccharide binding protein. Science, 249 (4975), 1429-31.
10. Ha, Y. L. and Barter, P. J. (1982) Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species. Comp. Biochemistry and Physiology, 71B, 265-72.
11. Guyard-Dangremont, V., Desrumaux, C., Gambert, P., Lallemant, C., Lagrost, L. (1998) Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Relation to atherogenesis susceptibility. Comp Biochem Physiol B Biochem Mol Biol, 120 (3), 517-25.
12. Breslow, J. L. (1996) Mouse models of atherosclerosis. Science, 272 (5262), 685-8.
13. Beamer, L. J., Carroll, S. F., Eisenberg, D. (1997) Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Protein Sci, 7, 906-914.
14. Bruce, C., Beamer, L. J., Tall, A. R. (1998) The implications of the structure of the bactericidal/permeability-increasing protein on the lipid-transfer function of the cholesteryl ester transfer protein. Curr Opin Struct Biol, 8 (4), 426-34.
15. Huuskonen, J., Wohlfahrt, G., Jauhiainen, M., Ehnholm, C., Teleman, O., Olkkonen, V. M. (1999) Structure and phospholipid transfer activity of human PLTP: analysis by molecular modeling and site-directed mutagenesis. J Lipid Res, 40 (6), 1123-30.
16. Gray, P. W., Corcorran, A. E., Eddy, R. L., Jr.,Byers, M. G., Shows, T. B. (1993) The genes for the lipopolysaccharide binding protein (LBP) and the bactericidal permeability increasing protein (BPI) are encoded in the same region of human chromosome 20. Genomics, 15 (1), 188-90.
17. Whitmore, T. E., Day, J. R., Albers, J. J. (1995) Localization of the human phospholipid transfer protein gene to chromosome 20q12-q13.1. Genomics, 28 (3), 599-600.
18. Hubacek, J. A., Buchler, C., Aslanidis, C., Schmitz, G. (1997) The genomic organization of the genes for human lipopolysaccharide binding protein (LBP) and bactericidal permeability increasing protein (BPI) is highly conserved. Biochem Biophys Res Commun, 236 (2), 427-30.
19. Kirschning, C. J., Au-Young, J., Lamping, N., Reuter, D., Pfeil, D., Seilhamer, J. J., Schumann, R. R. (1997) Similar organization of the lipopolysaccharide-binding protein (LBP) and phospholipid transfer protein (PLTP) genes suggests a common gene family of lipid-binding proteins. Genomics, 46 (3), 416-25.
20. Tu, A. Y., Deeb, S. S., Iwasaki, L., Day, J. R., Albers, J. J. (1995) Organization of human phospholipid transfer protein gene. Biochem Biophys Res Commun, 207 (2), 552-8.
21. Tu, A. Y., Wolfbauer, G., Albers, J. J. (1995) Functional characterization of the promoter region of the human phospholipid transfer protein gene. Biochem Biophys Res Commun, 217 (3), 705-11.
22. Li, W. H., Tanimura, M., Luo, C. C., Datta, S., Chan, L. (1988) The apolipoprotein multigene family: biosynthesis, structure, structurefunction relationships, and evolution. J Lipid Res, 29 (3), 245-71.
23. Albers, J. J., Wolfbauer, G., Cheung, M. C., Day, J. R., Ching, A. F. T., Lok, S., Tu, A.-Y. (1995) Functional expression of human and mouse plasma phospholipid transfer protein: effect of recombinant and plama PLTP on HDL subspecies. Biochimica et biophysica acta, 1258, 27-34.
24. Huuskonen, J., Jauhiainen, M., Ehnholm, C., Olkkonen, V. M. (1998) Biosynthesis and secretion of human plasma phospholipid transfer protein. J Lipid Res, 39 (10), 2021-2030.
25. Qu, S. J., Fan, H. Z., Gillard, B. K., Pownall, H. J. (2006) N-glycosylation is required for secretion-competent human plasma phospholipid transfer protein. Protein J, 25, 167-173.
26. Huuskonen, J., Olkkonen, V. M., Jauhiainen, M., Sareneva, T., Somerharju, P., Ehnholm, C. (1998b) Oxidative modification of HDL3 in vitro and its effect on PLTP-mediated phospholipid transfer. Biochim Biophys Acta, 1391 (2), 181-92.
27. Albers, J. J., Tu, A. Y., Wolfbauer, G., Cheung, M. C., Marcovina, S. M. (1996b) Molecular biology of phospholipid transfer protein. Curr Opin Lipidol, 7 (2), 88-93.
28. Tu, A. Y. and Albers, J. J. (2001) Functional analysis of the transcriptional activity of the mouse phospholipid transfer protein gene. Biochem Biophys Res Commun, 287 (4), 921-6.
29. Laffitte, B. A., Joseph, S. B., Chen, M., Castrillo, A., Repa, J., Wilpitz, D., Mangelsdorf, D., Tontonoz, P. (2003) The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions. Mol Cell Biol, 23 (6), 2182-91.
30. Chawla, A., Repa, J. J., Evans, R. M., Mangelsdorf, D. J. (2001) Nuclear receptors and lipid physiology: opening the X-files. Science, 294 (5548), 1866-70.
31. Urizar, N. L., Dowhan, D. H., Moore, D. D. (2000) The farnesoid Xactivated receptor mediates bile acid activation of phospholipid transfer protein gene expression. J Biol Chem, 275 (50), 39313-7.
32. Kast, H. R., Nguyen, C. M., Sinal, C. J., Jones, S. A., Laffitte, B. A., Reue, K., Gonzalez, F. J., Willson, T. M., Edwards, P. A. (2001) Farnesoid Xactivated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids. Mol Endocrinol, 15 (10), 1720-8.
33. Brown, W. V. (1987) Potential use of fenofibrate and other fibric acid derivatives in the clinic. Am J Med, 83 (5B), 85-9.
34. Tu, A. Y. and Albers, J. J. (1999) DNA sequences responsible for reduced promoter activity of human phospholipid transfer protein by fibrate. Biochem Biophys Res Commun, 264 (3), 802-7.
35. Tontonoz, P. and Mangelsdorf, D. J. (2003) Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol, 17, 985-993.
36. Lehmann, J. M., Kliewer, S. A., Moore, L. B., Smith-Oliver, T. A., Oliver, B. B., Su, J. L., Sundseth, S. S., Winegar, D. A., Blanchard, D. E., Spencer, T. A., Willson, T. M. (1997) Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem, 272 (6), 3137-40.
37. Laffitte, B. A., Repa, J. J., Joseph, S. B., Wilpitz, D. C., Kast, H. R., Mangelsdorf, D. J., Tontonoz, P. (2001) LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc Natl Acad Sci USA, 98 (2), 507-12.
38. Zhang, Y., Repa, J. J., Gauthier, K., Mangelsdorf, D. J. (2001) Regulation of lipoprotein lipase by the oxysterol receptors, LXRalpha and LXRbeta. J Biol Chem, 276 (46), 43018-24.
39. Kennedy, M. A., Venkateswaran, A., Tarr, P. T., Xenarios, I., Kudoh, J., Shimizu, N., Edwards, P. A. (2001) Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein. J Biol Chem, 276 (42), 39438-47.
40. Repa, J. J., Berge, K. E., Pomajzl, C., Richardson, J. A., Hobbs, H., Mangelsdorf, D. J. (2002) Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem, 277 (21), 18793-800.
41. Joseph, S. B., Laffitte, B. A., Patel, P. H., Watson, M. A., Matsukuma, K. E., Walczak, R., Collins, J. L., Osborne, T. F., Tontonoz, P. (2002) Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem, 277 (13), 11019-25.
42. Edwards, P. A., Kast, H. R., Anisfeld, A. M. (2002) BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. J Lipid Res, 43 (1), 2-12.
43. Cao, G., Beyer, T. P., Yang, X. P., Schmidt, R. J., Zhang, Y., Bensch, W. R., Kauffman, R. F., Gao, H., Ryan, T. P., Liang, Y., Eacho, P. I., Jiang, X. C. (2002) Phospholipid transfer protein is regulated by liver X receptors in vivo. J Biol Chem, 277 (42), 39561-5.
44. Mak, P. A., Kast-Woelbern, H. R., Anisfeld, A. M., Edwards, P. A. (2002) Identification of PLTP as an LXR target gene and apoE as an FXR target gene reveals overlapping targets for the two nuclear receptors. J Lipid Res, 43 (12), 2037-41.
45. Schultz, J. R., Tu, H., Luk, A., Repa, J. J., Medina, J. C., Li, L., Schwendner, S., Wang, S., Thoolen, M., Mangelsdorf, D. J., Lustig, K. D., Shan, B. (2000) Role of LXRs in control of lipogenesis. Genes Dev, 14 (22), 2831-8.
46. Beyer, T. P., Schmidt, R. J., Foxworthy, P., Zhang, Y., Dai, J., Bensch, W. R., Kauffman, R. F., Gao, H., Ryan, T. P., Jiang, X. C., Karathanasis, S. K., Eacho, P. I., Cao, G. (2004) Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-alpha agonist in mice: effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo. J Pharmacol Exp Ther, 309 (3), 861-8.
47. Tall, A., Krumholz, S., Olivecrona, T., Deckelbaum, R. (1985) Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis. Journal of Lipid Research, 26, 842-851.
48. Huuskonen, J., Olkkonen, V. M., Jauhiainen, M., Metso, J., Somerharju, P., Ehnholm, C. (1996) Acyl chain and headgroup specificity of human plasma phospholipid transfer protein. Biochim Biophys Acta, 1303 (3), 207-14.
49. Rao, R., Albers, J. J., Wolfbauer, G., Pownall, H. J. (1997) Molecular and macromolecular specificity of human plasma phospholipid transfer protein. Biochemistry, 36 (12), 3645-53.
50. Brown, M. L., Hesler, C., Tall, A. R. (1990) Plasma enzymes and transfer proteins in cholesterol metabolism. Curr Opin Lipidology, 1, 122-127.
51. Jiang, X. C., Bruce, C., Mar, J., Lin, M., Ji, Y., Francone, O. L., Tall, A. R. (1999) Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J Clin Invest, 103 (6), 907-914.
52. Qin, S., Kawano, K., Bruce, C., Lin, M., Bisgaier, C., Tall, A. R., Jiang, X. (2000) Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins. J Lipid Res, 41 (2), 269-276.
53. Vieu, C., Jaspard, B., Barbaras, R., Manent, J., Chap, H., Perret, B., Collet, X. (1996) Identification and quantification of diacylglycerols in HDL and accessibility to lipase. J Lipid Res., 37, 1153-1161.
54. Kostner, G. M., Oettl, K., Jauhiainen, M., Ehnholm, C., Esterbauer, H., Dieplinger, H. (1995) Human plasma phospholipid transfer protein accelerates exchange/transfer of alpha-tocopherol between lipoproteins and cells. Biochem J, 305 (Pt 2), 659-67.
55. Hailman, E., Albers, J. J., Wolfbauer, G., Tu, A. Y., Wright, S. D. (1996) Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein. J Biol Chem, 271 (21), 12172-8.
56. Levels, J. H., Marquart, J. A., Abraham, P. R., vanden Ende, A. E., Molhuizen, H. O., vanDeventer, S. J., Meijers, J. C. (2005) Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharidebinding protein and phospholipid transfer protein. Infect Immun, 73 (4), 2321-6.
57. Nishida, H. I. and Nishida, T. (1997) Phospholipid transfer protein mediates transfer of not only phosphatidylcholine but also cholesterol from phosphatidylcholinecholesterol vesicles to high density lipoproteins. J Biol Chem, 272 (11), 6959-64.
58. Jiang, X. C., Tall, A. R., Qin, S., Lin, M., Schneider, M., Lalanne, F., Deckert, V., Desrumaux, C., Athias, A., Witztum, J. L., Lagrost, L. (2002) Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E. J Biol Chem, 277 (35), 31850-6.
59. Yang, X. P., Yan, D., Qiao, C., Liu, R. J., Chen, J. G., Li, J., Schneider, M., Lagrost, L., Xiao, X., Jiang, X. C. (2003) Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression. Arterioscler Thromb Vasc Biol, 23 (9), 1601-7.
60. Klein, A., Deckert, V., Schneider, M., Dutrillaux, F., Hammann, A., Athias, A., LeGuern, N., deBarros, J.-P.P., Desrumaux, C., Masson, D., Jiang, XC., Lagrost, L. (2006) α-Tocopherol modulates phosphatidylserine externalization in erythrocytes. Relevance in phospholipid transfer protein-deficient mice. Arteriscler Thromb Vasc Biol, 26, 2160-2167.
61. Desrumaux, C., Risold, P. Y., Schroeder, H., Deckert, V., Masson, D., Athias, A., Laplanche, H., LeGuern, N., Blache, D., Jiang, X. C., Tall, A. R., Desor, D., Lagrost, L. (2005) Phospholipid transfer protein (PLTP) deficiency reduces brain vitamin E content and increases anxiety in mice. Faseb J, 19 (2), 296-7.
62. Drouineaud, V., Lagrost, L., Klein, A., Desrumaux, C., LeGuern, N., Athias, A., Menetrier, F., Moiroux, P., Sagot, P., Jimenez, C., Masson, D., Deckert, V. (2006) Phospholipid transfer protein (PLTP) deficiency reduces sperm motility and impairs fertility of mouse males. FASEB J, 20, 794-806.
63. Jauhiainen, M., Metso, J., Pahlman, R., Blomqvist, S., vanTol, A., Ehnholm, C. (1993) Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem, 268 (6), 4032-6.
64. Tu, A. Y., Nishida, H. I., Nishida, T. (1993) High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J Biol Chem, 268 (31), 23098-105.
65. Lusa, S., Jauhiainen, M., Metso, J., Somerharju, P., Ehnholm, C. (1996) The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion. Biochem J, 313 (Pt 1), 275-82.
66. Korhonen, A., Jauhiainen, M., Ehnholm, C., Kovanen, P. T., Ala-Korpela, M. (1998) Remodeling of HDL by phospholipid transfer protein: demonstration of particle fusion by 1H NMR spectroscopy. Biochem Biophys Res Commun, 249 (3), 910-6.
67. Pownall, H. J. and Ehnholm, C. (2006) The unique role of apolipoprotein A-I in HDL remodeling and metabolism. Curr Opin Lipidol, 17, 209-213.
68. Pussinen, P., Jauhiainen, M., Metso, J., Tyynela, J., Ehnholm, C. (1995) Pig plasma phospholipid transfer protein facilitates HDL interconversion. J Lipid Res, 36 (5), 975-85.
69. Murakami, T., Michelagnoli, S., Longhi, R., Gianfranceschi, G., Pazzucconi, F., Calabresi, L., Sirtori, C. R., Franceschini, G. (1995) Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler Thromb Vasc Biol, 15 (11), 1819-28.
70. Rye, K. A., Jauhiainen, M., Barter, P. J., Ehnholm, C. (1998) Triglycerideenrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein. J Lipid Res, 39 (3), 613-22.
71. Sviridov, D., Miyazaki, O., Theodore, K., Hoang, A., Fukamachi, I., Nestel, P. (2002) Delineation of the role of pre-beta 1-HDL in cholesterol efflux using isolated pre-beta 1-HDL. Arterioscler Thromb Vasc Biol, 22 (9), 1482-8.
72. Marques-Vidal, P., Jauhiainen, M., Metso, J., Ehnholm, C. (1997) Transformation of high density lipoprotein 2 particles by hepatic lipase and phospholipid transfer protein. Atherosclerosis, 133 (1), 87-95.
73. Syvanne, M., Castro, G., Dengremont, C., DeGeitere, C., Jauhiainen, M., Ehnholm, C., Michelagnoli, S., Franceschini, G., Kahri, J., Taskinen, M. R. (1996) Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulindependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein. Atherosclerosis, 127 (2), 245-53.
74. Wolfbauer, G., Albers, J. J., Oram, J. F. (1999) Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins. Biochim Biophys Acta, 1439 (1), 65-76.
75. Oram, J. F., Wolfbauer, G., Vaughan, A. M., Tang, C., Albers, J. J. (2003) Phospholipid transfer protein interacts with and stabilizes ATPbinding cassette transporter A1 and enhances cholesterol efflux from cells. J Biol Chem, 278 (52), 52379-85.
76. Francone, O. L., Subbaiah, P. V., vanTol, A., Royer, L., Haghpassand, M. (2003) Abnormal phospholipid composition impairs HDL biogenesis and maturation in mice lacking Abca1. Biochemistry, 42 (28), 8569-78.
77. vonEckardstein, A., Jauhiainen, M., Huang, Y., Metso, J., Langer, C., Pussinen, P., Wu, S., Ehnholm, C., Assmann, G. (1996) Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL. Biochim Biophys Acta, 1301 (3), 255-62.
78. vanHaperen, R., vanTol, A., Vermeulen, P., Jauhiainen, M., vanGent, T., vandenBerg, P., Ehnholm, S., Grosveld, F., vanderKamp, A., deCrom, R. (2000) Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. Arterioscler Thromb Vasc Biol, 20 (4), 1082-8.
79. Lee, M., Metso, J., Jauhiainen, M., Kovanen, P. T. (2003) Degradation of phospholipid transfer protein (PLTP) and PLTP-generated pre-beta-high density lipoprotein by mast cell chymase impairs high affinity efflux of cholesterol from macrophage foam cells. J Biol Chem, 278 (15), 13539-45.
80. Valenta, D. T., Ogier, L., Bradshaw, G., Black, A. S., Bonnet, D. J., Lagrost, L., Curtiss, L. K., Desrumaux, C. M. (2006) Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein A-I overproduction. Arterioscler Thromb Vasc Biol, 26, 1572-1580.
81. Mallow, M. J., Zoppo, A., Tu, A.-Y., O'Connor, P., Kunitake, S. T., Hamilton, R. L., Robbins, E., Fielding, C., Kane, J. P. (1994) A new metabolic disorder: phospholipid transfer protein deficiency. Clinical Research, 42:85 Abstract.
82. Aquizerat, B. E., Engler, M. B., Natnzon, Y., Kulkarni, M., Song, J., Eng, C., Huuskonen, J., Rivera, C., Poon, A., Bensley, M., Schnert, A., Zellner, C., Malloy, M., Kane, J., Pullinger, C. R. (2006) Genetic variation of PLTP modulated lipoprotein profiles in hypoalphalipoproteinemia. J Lipid Res, 47, 787-793.
83. Tahvanainen, E., Jauhiainen, M., Funke, H., Vartiainen, E., Sundvall, J., Ehnholm, C. (1999) Serum phospholipid transfer protein activity and genetic variation of the PLTP gene. Atherosclerosis, 146 (1), 107-15.
84. Murdoch, S. J., Carr, M. C., Hokanson, J. E., Brunzell, J. D., Albers, J. J. (2000) PLTP activity in premenopausal women. Relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance. J Lipid Res, 41 (2), 237-44.
85. Cheung, M. C., Knopp, R. H., Retzlaff, B., Kennedy, H., Wolfbauer, G., Albers, J. J. (2002) Association of plasma phospholipid transfer protein activity with IDL and buoyant LDL: impact of gender and adiposity. Biochim Biophys Acta, 1587 (1), 53-9.
86. Murdoch, S. J., Carr, M. C., Kennedy, H., Brunzell, J. D., Albers, J. J. (2002b.) Selective and independent associations of phospholipid transfer protein and hepatic lipase with the LDL subfraction distribution. J Lipid Res, 43 (8), 1256-63.
87. Kujiraoka, T., Nanjee, M. N., Oka, T., Ito, M., Nagano, M., Cooke, C. J., Takahashi, S., Olszewski, W. L., Wong, J. S., Stepanova, I. P., Hamilton, R. L., Egashira, T., Hattori, H., Miller, N. E. (2003) Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on LCAT, PLTP, and CETP in plasma and peripheral lymph in humans. Arterioscler Thromb Vasc Biol, 23 (9), 1653-9.
88. Dullaart, R. P. and vanTol, A. (2001) Role of phospholipid transfer protein and prebeta-high density lipoproteins in maintaining cholesterol efflux from Fu5AH cells to plasma from insulin-resistant subjects. Scand J Clin Lab Invest, 61 (1), 69-74.
89. Dullaart, R. P. and vanTol, A. (2001b) Short-term Acipimox decreases the ability of plasma from Type 2 diabetic patients and healthy subjects to stimulate cellular cholesterol efflux: a potentially adverse effect on reverse cholesterol transport. Diabet Med, 18 (6), 509-13.
90. Dullaart, R. P., Sluiter, W. J., Dikkeschei, L. D., Hoogenberg, K., VanTol, A. (1994b) Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest, 24 (3), 188-94.
91. Riemens, S. C., vanTol, A., Sluiter, W. J., Dullaart, R. P. (1998b) Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients. Diabetologia, 41 (8), 929-34.
92. Kaser, S., Sandhofer, A., Foger, B., Ebenbichler, C. F., Igelseder, B., Malaimare, L., Paulweber, B., Patsch, J. R. (2001b) Influence of obesity and insulin sensitivity on phospholipid transfer protein activity. Diabetologia, 44 (9), 1111-7.
93. Tzotzas, T., Dumont, L., Triantos, A., Karamouzis, M., Constantinidis, T., Lagrost, L. (2006) Early decreases in plasma lipid transfer proteins during weight reduction. Obesity, 14, 1038-1045.
94. Riemens, S. C., VanTol, A., Sluiter, W. J., Dullaart, R. P. (1999) Acute and chronic effects of a 24-hour intravenous triglyceride emulsion challenge on plasma lecithin: cholesterol acyltransferase, phospholipid transfer protein, and cholesteryl ester transfer protein activities. J Lipid Res, 40 (8), 1459-66.
95. Murdoch, S. J., Kahn, S. E., Albers, J. J., Brunzell, J. D., Purnell, J. Q. (2003) PLTP activity decreases with weight loss: changes in PLTP are associated with changes in subcutaneous fat and FFA but not IAF or insulin sensitivity. J Lipid Res, 44 (9), 1705-12.
96. Kaser, S., Laimer, M., Sandhofer, A., Salzmann, K., Ebenbichler, C. F., Patsch, J. R. (2004) Effects of weight loss on PLTP activity and HDL particle size. Int J Obes Relat Metab Disord, 28 (10), 1280-2.
97. Colhoun, H. M., Scheek, L. M., Rubens, M. B., VanGent, T., Underwood, S. R., Fuller, J. H., VanTol, A. (2001) Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification. Diabetes, 50 (3), 652-9.
98. Colhoun, H. M., Taskinen, M. R., Otvos, J. D., Van DenBerg, P., O'Connor, J., VanTol, A. (2002) Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetes. Diabetes, 51 (11), 3300-5.
99. Riemens, S., van Tol, A., Sluiter, W., Dullaart, R. (1998) Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein. Atherosclerosis, 140 (1), 71-9.
100. Jonkers, I. J., Smelt, A. H., Hattori, H., Scheek, L. M., van Gent, T., de Man, F. H., vander Laarse, A., van Tol, A. (2003) Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG: effects of bezafibrate therapy. J Lipid Res, 44 (8), 1462-9.
101. Kaser, S., Foger, B., Ebenbichler, C. F., Kirchmair, R., Gander, R., Ritsch, A., Sandhofer, A., Patsch, J. R. (2001) Influence of leptin and insulin on lipid transfer proteins in human hepatoma cell line, HepG2. Int J Obes Relat Metab Disord, 25 (11), 1633-1639.
102. Schlitt, A., Bickel, C., Thumma, P., Blankenberg, S., Rupprecht, H. J., Meyer, J., Jiang, X. C. (2003) High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol, 23 (10), 1857-62.
103. Cheung, M. C., Brown, B. G., Marino Larsen, E. K., Frutkin, A. D., O'Brien, K. D., Albers, J. J. (2006) Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease. Biochim Biophys Acta, 1762, 131-137.
104. Dullaart, R. P., Hoogenberg, K., Dikkeschei, B. D., van Tol, A. (1994) Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. Arterioscler Thromb, 14 (10), 1581-5.
105. Lagrost, L., Athias, A., Herbeth, B., Guyard-Dangremont, V., Artur, Y., Paille, F., Gambert, P., Lallemant, C. (1996) Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. Physiological relevance in alcoholic patients. J Biol Chem, 271 (32), 19058-65.
106. Liinamaa, M. J., Hannuksela, M. L., Kesaniemi, Y. A., Savolainen, M. J. (1997) Altered transfer of cholesteryl esters and phospholipids in plasma from alcohol abusers. Arterioscler Thromb Vasc Biol, 17 (11), 2940-7
107. van Tol, A., Urgert, R., deJong-Caesar, R., van Gent, T., Scheek, L. M., de Roos, B., Katan, M. B. (1997) The cholesterol-raising diterpenes from coffee beans increase serum lipid transfer protein activity levels in humans. Atherosclerosis, 132 (2), 251-4.
108. De Roos, B., Van Tol, A., Urgert, R., Scheek, L. M., Van Gent, T., Buytenhek, R., Princen, H. M., Katan, M. B., (2000) Consumption of French-press coffee raises cholesteryl ester transfer protein activity levels before LDL cholesterol in normolipidaemic subjects. J Intern Med, 248 (3), 211-6.
109. Desrumaux, C. M., Mak, P. A., Boisvert, W. A., Masson, D., Stupack, D., Jauhiainen, M., Ehnholm, C., Curtiss, L. K. (2003) Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells. J Lipid Res, 44 (8), 1453-61.
110. O'Brien, K. D., Vuletic, S., McDonald, T. O., Wolfbauer, G., Lewis, K., Tu, A. Y., Marcovina, S., Wight, T. N., Chait, A., Albers, J. J. (2003) Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis. Circulation, 108 (3), 270-4.
111. Vuletic, S., Jin, L. W., Marcovina, S. M., Peskind, E. R., Moller, T., Albers, J. J. (2003) Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease. J Lipid Res, 44 (6), 1113-23.
112. Vuletic, S., Peskind, E. R., Marcovina, S. M., Quinn, J. F., Cheung, M. C., Kennedy, H., Kaye, J. A., Jin, L. W., Albers, J. J. (2005) Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro. J Neurosci Res, 80 (3), 406-413.
113. Krapfenbauer, K., Yoo, B. C., Kim, S. H., Cairns, N., Lubec, G. (2001) Differential display reveals downregulation of the phospholipid transfer protein (PLTP) at the mRNA level in brains of patients with Down syndrome. Life Sci, 68 (18), 2169-79.
114. Masson, D., Drouineaud, V., Moiroux, P., Gautier, T., Dautin, G., Schneider, M., Fruchart-Najib, J., Jauhiainen, M., Ehnholm, C., Sagot, P., Gambert, P., Jimenez, C., Lagrost, L. (2003) Human seminal plasma displays significant phospholipid transfer activity due to the presence of active phospholipid transfer protein. Mol Hum Reprod, 9 (8), 457-64.
115. Jauhiainen, M., Setala, N. L., Ehnholm, C., Metso, J., Tervo, T. M., Eriksson, O., Holopainen, J. M. (2005) Phospholipid Transfer Protein Is Present in Human Tear Fluid. Biochemistry, 44 (22), 8111-8116.
116. Jiang, X. C., D'Armiento, J., Mallampalli, R. K., Mar, J., Yan, S. F., Lin, M. (1998) Expression of plasma phospholipid transfer protein mRNA in normal and emphysematous lungs and regulation by hypoxia. J Biol Chem, 273 (25), 15714-8.
117. Desrumaux, C., Athias, A., Bessede, G., Verges, B., Farnier, M., Persegol, L., Gambert, P., Lagrost, L. (1999) Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulindependent diabetic subjects as measured by a specific ELISA. Arterioscler Thromb Vasc Biol, 19 (2), 266-75.
118. Oka, T., Kujiraoka, T., Ito, M., Egashira, T., Takahashi, S., Nanjee, M. N., Miller, N. E., Metso, J., Olkkonen, V. M., Ehnholm, C., Jauhiainen, M., Hattori, H. (2000) Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive. J Lipid Res, 41 (10), 1651-1657.
119. Oka, T., Kujiraoka, T., Ito, M., Nagano, M., Ishihara, M., Iwasaki, T., Egashira, T., Miller, N. E., Hattori, H. (2000) Measurement of human plasma phospholipid transfer protein by sandwich ELISA. Clin Chem, 46 (9), 1357-64.
120. Siggins, S., Kärkkäinen, M., Tenhunen, J., Metso, J., Tahvanainen, E., Olkkonen, V. M., Jauhiainen, M., Ehnholm, C. (2004) Quantitation of the active and low-active forms of human plasma phospholipid transfer protein by ELISA. J Lipid Res, 45, 387-395.
121. Jaari, S., van Dijk, K. W., Olkkonen, V. M., van der Zee, A., Metso, J., Havekes, L., Jauhiainen, M., Ehnholm, C. (2001) Dynamic changes in mouse lipoproteins induced by transiently expressed human phospholipid transfer protein (PLTP): importance of PLTP in prebeta-HDL generation. Comp Biochem Physiol B Biochem Mol Biol, 128 (4), 781-92.
122. Kärkkäinen, M., Oka, T., Olkkonen, V. M., Metso, J., Hattori, H., Jauhiainen, M., Ehnholm, C. (2002) Isolation and partial characterization of the inactive and active forms of human plasma phospholipid transfer protein (PLTP). J Biol Chem, 277 (18), 15413-8.
123. Siggins, S., Jauhiainen, M., Olkkonen, V. M., Tenhunen, J., Ehnholm, C. (2003) PLTP secreted by HepG2 cells resembles the highactivity PLTP form in human plasma. J Lipid Res, 44, 1698-1704.
124. Jänis, M. T., Metso, J., Lankinen, H., Strandin, T., Olkkonen, V. M., Rye, K. A., Jauhiainen, M., Ehnholm, C. (2005) Apolipoprotein E activates the low-activity form of human phospholipid transfer protein. Biochem Biophys Res Commun, 331 (1), 333-40.
125. Tan, K. C. B., Shiu, S. W. M., Wong, Y., Wong, W. K., Tam, S. (2006) Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitus. Diabetes Metab Res Rev, 22, 307-312.
126. Dallinga-Thie, G. M., van Tol, A., Hattori, H., Rensen, P. C., Sijbrands, E. J. (2006) Plasma phospholipid transfer protein activity is decreased in type 2 diabetes during treatment with atorvastatin: a role for apolipoprotein E?Diabetes, 55, 1491-1496.
127. Jänis, M. T., Siggins, S., Tahvanainen, E., Vikstedt, R., Silander, K., Metso, J., Aromaa, A., Taskinen, M-R., Olkkonen, V. M., Jauhiainen, M., Ehnholm, C. (2004) Active and lowactive forms of serum phospholipid transfer protein in a normal Finnish population sample. J Lipid Res, 45, 2303-2309.
128. Paigen, B., Plump, A. S., Rubin, E. M. (1994) The mouse as a model for human cardiovascular disease and hyperlipidemia. Curr Opin Lipidol, 5 (4), 258-64.
129. Jiang, X., Francone, O. L., Bruce, C., Milne, R., Mar, J., Walsh, A., Breslow, J. L., Tall, A. R. (1996) Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. J Clin Invest, 98 (10), 2373-80.
130. Albers, J. J., Tu, A. Y., Paigen, B., Chen, H., Cheung, M. C., Marcovina, S. M. (1996) Transgenic mice expressing human phospholipid transfer protein have increased HDL/non-HDL cholesterol ratio. Int J Clin Lab Res, 26 (4), 262-7.
131. Foger, B., Santamarina-Fojo, S., Shamburek, R. D., Parrot, C. L., Talley, G. D., Brewer, H. B., Jr. (1997) Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL. J Biol Chem, 272 (43), 27393-400.
132. Ehnholm, S., vanDijk, K. W., van't Hof, B., vanderZee, A., Olkkonen, V. M., Jauhiainen, M., Hofker, M., Havekes, L., Ehnholm, C. (1998) Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice. J Lipid Res, 39 (6), 1248-53.
133. Van Haperen, R., Van Tol, A., Van Gent, T., Scheek, L., Visser, P., Van Der Kamp, A., Grosveld, F., De Crom, R. (2002) Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein. J Biol Chem, 277 (50), 48938-48943.
134. Lie, J., d., C. R., van Gent, T., van Haperen, R., Scheek, L., Lankhuizen, I., van Tol, A. (2002) Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion. J Lipid Res, 43 (11), 1875-80.
135. Lie, J., de Crom, R., van Gent, T., van Haperen, R., Scheek, L., Sadeghi-Niaraki, F., van Tol, A. (2004) Elevation of plasma phospholipid transfer protein increases the risk of atherosclerosis despite lower apolipoprotein B-containing lipoproteins. J Lipid Res, 45 (5), 805-11.
136. Kawano, K., Qin, S. C., Lin, M., Tall, A. R., Jiang, X. C. (2000) Cholesteryl ester transfer protein and phospholipid transfer protein have nonoverlapping functions in vivo. J Biol Chem, 275 (38), 29477-81.
137. Kawano, K., Qin, S., Vieu, C., Collet, X., Jiang, X. C. (2002) Role of hepatic lipase and scavenger receptor BI in clearing phospholipid/free cholesterol-rich lipoproteins in PLTPdeficient mice. Biochim Biophys Acta, 1583 (2), 133-40.
138. Jiang, X. C., Qin, S., Qiao, C., Kawano, K., Lin, M., Skold, A., Xiao, X., Tall, A. R. (2001) Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipidtransfer protein deficiency. Nat Med, 7 (7), 847-52.
139. Jiang, X. C., Li, Z., Liu, R., Yang, X. P., Pan, M., Lagrost, L., Fisher, E. A., Williams, K. J. (2005) Phospholipid transfer protein deficiency impairs apolipoprotein-B secretion from hepatocytes by stimulating a proteolytic pathway through a relative deficiency of vitamin E and an increase in intracellular oxidants. J Biol Chem, 280 (18), 18336-40.
140. Yan, D., Navab, M., Bruce, C., Fogelman, A. M., Jiang, X. C. (2004) PLTP deficiency improves the antiinflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity. J Lipid Res, 45 (10), 1852-8.
141. Barlage, S., Frohlich, D., Bottcher, A., Jauhiainen, M., Muller, H. P., Noetzel, F., Rothe, G., Schutt, C., Linke, R. P., Lackner, K. J., Ehnholm, C., Schmitz, G. (2001) ApoEcontaining high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. J Lipid Res, 42 (2), 281-90.
142. Huuskonen, J. and Ehnholm, C. (2000) Phospholipid transfer protein in lipid metabolism. Curr Opin Lipidol, 11 (3), 285-289.
143. LeBoeuf, R. C., Caldwell, M., Tu, A., Albers, J. J. (1996) Phospholipid transfer protein maps to distal mouse chromosome 2. Genomics, 34 (2), 259-60.
144. Murdoch, S. J., Wolfbauer, G., Kennedy, H., Marcovina, S. M., Carr, M. C., Albers, J. J. (2002) Differences in reactivity of antibodies to active versus inactive PLTP significantly impacts PLTP measurement. J Lipid Res, 43 (2), 281-9.
145. Riemens, S. C., van Tol, A., Sluiter, W. J., Dullaart, R. P. (1999b) Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients. Diabetes, 48 (8), 1631-7.
146. Tu, A. Y., Chen, H., Johnson, K. A., Paigen, B., Albers, J. J. (1997) Characterization of the mouse gene encoding phospholipid transfer protein. Gene, 188 (1), 115-8.